Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433622
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-06-13
First Post:
2024-04-30
Brief Title:
Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy Repeat TEG-PM
Sponsor:
Lancaster General Hospital
Organization:
Lancaster General Hospital
Study Overview
Official Title:
Platelet Transfusion and Repeat Thromboelastography With Platelet Mapping TEG-PM in Patients With Severe Traumatic Brain Injuries TBI on Antiplatelet Therapy
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to see if administering platelets cells in our blood that stop or prevent bleeding results in improved platelet function and slowsstops the progression of a head bleed for patients who have a traumatic head bleed and are on antiplatelet therapy medications that stop blood cells from forming a blood clot prior to admission
Detailed Description:
This study aims to determine if platelet function has improved following platelet transfusion by prospectively performing repeat thromboelastographic with platelet mapping TEG-PM assays on all patients consented and enrolled in the study This study will also examine the rate of progression or stability of ICH on repeat head CT following platelet administration and will aid in the determination of a potential association between repeat CT head findings and the repeat TEG-PM results
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None